SPONSOR
Northwestern University
Total Trials
16
Recruiting
16
Phases
Phase 2
Conditions studied: Advanced Biliary Tract CarcinomaAdvanced Colorectal CarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaAdvanced Lung AdenocarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian CarcinomaAdvanced Pancreatic CarcinomaAdvanced Urothelial CarcinomaClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
Northwestern University is a clinical research sponsor with 16 registered studies on ClinicalTrials.gov, of which 16 are actively recruiting participants. Research covers conditions including Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Advanced Lung Adenocarcinoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Northwestern University
How many clinical trials has Northwestern University sponsored?
ClinicalMetric currently tracks 16 clinical trials sponsored by Northwestern University, of which 16 are actively recruiting participants. These trials cover conditions including Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Northwestern University research focus on?
Northwestern University clinical trials span Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Advanced Lung Adenocarcinoma, Advanced Malignant Solid Neoplasm, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Northwestern University clinical trial?
To participate in a Northwestern University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Northwestern University trials with current recruitment status updated daily.
Clinical Trials by Northwestern University
NCT05733000 Phase 2
Recruiting
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Advanced Biliary Tract Carcinoma
NCT01644903
Recruiting
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Liver Transplant
NCT06698146
Recruiting
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
Liver Transplant Surgery
NCT07498140
Recruiting
Procedural Framing and Epidural Steroid Injection Outcomes
Lumbosacral Radiculopathy
NCT06118528
Recruiting
EAT: A Reliable Eating Assessment Technology for Free-living Individuals
Wearable Electronic Device
NCT06996379
Recruiting
J-Tip Use for Paracentesis in Adults With Ascites
Evaluate Patient Comfort Level During Paracentesis by Numbing Skin With a Needle-less Device, Instead of Using a Needle to Numb the Skin
NCT06598150
Recruiting
Mapping Corticoreticulospinal Motor Control in Chronic Hemiparetic Stroke
Stroke
NCT07225023
Recruiting
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy for Dizziness
Dizziness
NCT03577327
Recruiting
The Gut and Skin Microbiome in Vitiligo Disease Progression
Vitiligo
NCT07050186 Phase 2
Recruiting
Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
Metastatic NUT Carcinoma
NCT07586046 Phase 2
Recruiting
Defining the Ablative Dose for Y-90 TARE
HCC - Hepatocellular Carcinoma
NCT07542769
Recruiting
Choice and Autonomy in Learning Mindfulness for Pediatric Residents
Program Engagement
NCT05369429
Recruiting
My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life
Cancer
NCT06496659
Recruiting
Segmentectomy After Induction Therapy (SAINT)
Segmentectomy
NCT06617871
Recruiting
Mechanical Alignment vs Kalipered Kinematic Alignment Total Knee Arthroplasty
Knee Osteoarthritis
NCT07632742
Recruiting
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
Enlarged Prostate (BPH)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology